Create a free account or log in.
AB Science is a late-clinical-stage French company founded in 2001 by a team of scientists with the goal of developing innovative drugs for high unmet medical needs.
The Company is based in Paris and has been listed on Euronext since 2010 (compartment B, Paris, France).
AB Science has over 100 employees, mostly dedicated to R&D activities.
AB Science is currently developing two main compounds, masitinib, a highly selective tyrosine kinase inhibitor and AB8939, a new generation microtubule destabilizer.
In human medicine, AB Science has a unique indication portfolio with multiple late-stage programs including blockbuster potential and orphan diseases.
Masitinib has already generated positive phase 2B/3 results in Amyotrophic Lateral Sclerosis, Indolent Systemic Mastocytosis, Severe Asthma, Progressive Forms of Multiple Sclerosis, First Line Pancreatic Cancer with Pain, Alzheimer’s Disease and Metastatic Castrate-Resistant Prostate Cancer.
100
Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).
| Filing Information | Date & Language | Document Details | Actions |
|---|
No filings found matching your criteria
IKM
Sector
Health Care
Country
Spain
ISIN
Founded
1NKEMIA specializes in biotechnology research and innovation, offering advanced solutions for the pharmaceutical, chemical, and energy sectors.
2CUREX
Sector
Health Care
Country
Sweden
ISIN
SE0010468124
Founded
2cureX AB is a Danish biotech company specializing in functional precision medicine. It develops diagnostic tools to personalize cancer treatment.
VSC
Sector
Health Care
Country
Germany
ISIN
DE000A3E5C40
Founded
1997
4SC focuses on the development of novel small molecule drugs that target key mechanisms of cancer development, such as histone …
ABERA
Sector
Health Care
Country
Sweden
ISIN
SE0015245097
Founded
Abera Bioscience is active in biotechnology. The company specializes in the development of vaccines based on its own internal developed …
ABNX
Sector
Health Care
Country
France
ISIN
FR0012616852
Founded
ABIONYX Pharma is a new-generation biotech company that aims to contribute to health through innovative therapies in indications where there …
ABLI
Sector
Health Care
Country
Sweden
ISIN
SE0002575340
Founded
2000
Abliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when …